Bill Snyder

Stanley E. Graber, MD
December 21, 2023

Noted hematologist, teacher Stanley Graber dies at 85

Stanley E. Graber, MD, a retired professor and hematologist at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center, died Dec. 3 in Nashville.

By Bill Snyder
An array of ultrasound transducers covering the head focuses an ultrasound beam to a location deep in the brain associated with pain perception (bright spot). (illustration by Thomas Manuel, PhD)
December 20, 2023

Nonaddictive pain relief system nears clinical trials

Researchers in the Vanderbilt are nearing completion of an ingenious undertaking that may be a highpoint of their careers — a non-addictive alternative for relieving chronic pain.

By Bill Snyder
December 19, 2023

Three from VUMC elected to ASCI

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

By Bill Snyder
Ken Lau, PhD, left, and Bob Coffey, MD, have made several important discoveries about colorectal cancer that are aiding the search for new, more effective therapies. (photo by Erin O. Smith)
December 11, 2023

Colorectal cancer ‘cartography’ reveals an avenue to improved immunotherapy

Vanderbilt University Medical Center researchers have discovered why most colorectal tumors escape detection and destruction by the body’s immune system.

By Bill Snyder
Bob Coffey, MD
December 8, 2023

Vanderbilt research presented at Cancer Moonshot meet

Vanderbilt Colorectal cancer expert Bob Coffey, MD, was recently invited to present his research to representatives of President Joe Biden’s reignited Cancer Moonshot initiative.

By Bill Snyder
December 7, 2023

How to get the biggest “bang” for the research “buck”

Vanderbilt researchers are developing new methods to maximize what can be learned from clinical trials and cohort studies, while maintaining their rigor and reproducibility.

By Bill Snyder
December 5, 2023

Role of immunity in kidney injury hints at a potential therapy: study

Targeting the cytokine IL-22 could be a new therapeutic approach to prevent kidney injury caused by drugs or toxins, Vanderbilt researchers have discovered.
By Bill Snyder
December 4, 2023

Report offers a way to overcome the severe lack of HIV providers

In a new report, members of the Southeast AIDS Education and Training Center, which is coordinated by Vanderbilt University Medical Center, offers an innovative approach to increasing the HIV workforce: train all manner of health professionals to care for people with HIV.
By Bill Snyder
November 29, 2023

Nonprofits support quest to cure childhood epilepsy

Monica Joanna Elnekaveh was doing everything she could to learn what was causing her 18-month-old daughter’s developmental issues. Her relentless quest to find answers eventually led her to Vanderbilt investigative neurologist Jing-Qiong (Katty) Kang, MD, PhD.
By Bill Snyder
November 21, 2023

VUMC scientists discover key step to kidney fibrosis

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.
By Bill Snyder
November 17, 2023

Tumor antigens key to improving cancer immunotherapy: study

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.
By Bill Snyder
November 15, 2023

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.
By Bill Snyder
1 … 8 9 10 11 12 … 115